Hepatitis A hospitalizations among kidney transplant recipients in the United States: nationwide inpatient sample 2005–2014
- 1 May 2020
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 32 (5) , 650-655
Abstract
Background: This study aimed to evaluate the hospitalization rate for Hepatitis A virus (HAV) among kidney transplant (KTx) recipients and its outcomes as well as resource utilization. Methods: The 2005–2014 National Inpatient Sample database was used to identify all hospitalized KTx recipients with an associated diagnosis of HAV. The hospital mortality, resource utilization, and associated liver conditions were compared between patients with and without HAV, adjusting for potential confounders. Results: Of 871 024 KTx recipients identified, 204 had HAV. The overall inpatient prevalence of HAV in KTx recipients over 10 years in the United States was 23.42 cases per 100 000 admissions. There were no statistically significant changes in the inpatient prevalence of HAV in KTx recipients during the study period (P = 0.77), ranging from 9.2 to 34.3 per 100 000 admissions. Among hospitalized KTx recipients with HAV, 27.9% were from Northeast, 29.2% were from Midwest, 23.8% were from South, and 19.1% were from West. HAV was not significantly associated with increased hospital mortality, multiorgan failure, need for abdominal ultrasound, hospital length of stay, and total hospitalization costs and charges when compared with those without HAV. However, it is significantly associated with increased ICU stay, coexisting hepatitis B and C infection, and liver failure. Conclusion: Overall, inpatient prevalence of HAV in KTx recipients in the United States (years 2005–2014) was 23.42 cases per 100 000 admissions. Hospitalization for HAV after KTx is associated with increased ICU stay, coexisting hepatitis B and C infection, and liver failure.Keywords
This publication has 37 references indexed in Scilit:
- Hepatitis A: Epidemiology and prevention in developing countriesWorld Journal of Hepatology, 2012
- Hepatitis A: Clinical Manifestations and ManagementIntervirology, 2010
- Vaccination of Solid‐Organ Transplantation CandidatesClinical Infectious Diseases, 2009
- Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomesHepatology, 2006
- Vaccinations for Adult Solid-Organ Transplant Recipients: Current Recommendations and ProtocolsClinical Microbiology Reviews, 2003
- RAPID DECLINE OF ANTIBODIES AFTER HEPATITIS A IMMUNIZATION IN LIVER AND RENAL TRANSPLANT RECIPIENTSTransplantation, 2001
- Immunogenicity and Safety of Hepatitis A Vaccine in Liver and Renal Transplant RecipientsThe Journal of Infectious Diseases, 1999
- Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver diseaseHepatology, 1998
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- Management of acute and fulminant hepatitis AVaccine, 1992